Judith M Boer (Judith Boer)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 36

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Top Venues

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat C Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L Den Boer, Judith M Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke Katharina Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis Martin Schewe
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis. Blood 143 (26) (2024)
Inge van Outersterp, Judith M Boer, Cesca van de Ven, Caitlin E J Reichert, Aurelie Boeree, Brian Kruisinga, Hester A de Groot-Kruseman, Gabriele Escherich, Aniko Sijs-Szabo, Anita W Rijneveld, Monique L den Boer
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations. Blood advances 8 (8) (2024)
Emma Kroeze, Ingram Iaccarino, Michelle M Kleisman, Mayukh Mondal, Thomas Beder, Mouhamad Khouja, Marc P Höppner, Marijn A Scheijde-Vermeulen, Lennart A Kester, Monika Brüggemann, Claudia D Baldus, Gunnar Cario, Reno S Bladergroen, Nathalie Garnier, Andishe Attarbaschi, Jaime Verdu-Amorós, Rosemary Sutton, Elizabeth A Macintyre, Kenneth Scholten, Laura Arias Padilla, Birgit Burkhardt, Auke Beishuizen, Monique L den Boer, Roland P Kuiper, Jan L C Loeffen, Judith M Boer, Wolfram Klapper
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma. Blood (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia (2024)
Judith M Boer, Uri Ilan, Aurélie Boeree, Karin P S Langenberg, Jan Koster, Marco J Koudijs, Jayne Y Hehir-Kwa, Stefan Nierkens, Corinne Rossi, Jan J Molenaar, Bianca F Goemans, Monique L den Boer, C Michel Zwaan
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience. HemaSphere 8 (7) (2024)
Inge van Outersterp, Judith M Boer, Cesca Van De Ven, Caitlin Ej Reichert, Aurélie Boeree, Brian Kruisinga, Hester A de Groot-Kruseman, Gabriele Escherich, Aniko Sijs-Szabo, Anita W Rijneveld, Monique L den Boer
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations. Blood advances (2024)
Inge van Outersterp, Sarah K Tasian, Caitlin E J Reichert, Aurélie Boeree, Hester A de Groot-Kruseman, Gabriele Escherich, Judith M Boer, Monique L Den Boer
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain. Blood 143 (21) (2024)
Emma Kroeze, Ingram Iaccarino, Michelle M Kleisman, Mayukh Mondal, Thomas Beder, Mouhamad Khouja, Marc P Höppner, Marijn A Scheijde-Vermeulen, Lennart A Kester, Monika Brüggemann, Claudia D Baldus, Gunnar Cario, Reno S Bladergroen, Nathalie Garnier, Andishe Attarbaschi, Jaime Verdu-Amorós, Rosemary Sutton, Elizabeth Macintyre, Kenneth Scholten, Laura Arias Padilla, Birgit Burkhardt, Auke Beishuizen, Monique L den Boer, Roland P Kuiper, Jan L C Loeffen, Judith M Boer, Wolfram Klapper
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma. Blood 144 (1) (2024)
Inge van Outersterp, Judith M Boer, Cesca Van De Ven, Caitlin EJ Reichert, Aurélie Boeree, Brian Kruisinga, Hester A de Groot-Kruseman, Gabriele Escherich, Aniko Sijs-Szabo, Anita W Rijneveld, Monique L den Boer
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations. Blood advances (2024)
Inge van Outersterp, Judith M Boer, Cesca van de Ven, Caitlin E J Reichert, Aurelie Boeree, Brian Kruisinga, Hester A de Groot-Kruseman, Gabriele Escherich, Aniko Sijs-Szabo, Anita W Rijneveld, Monique L den Boer
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations. Blood advances 8 (8) (2024)
Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat C Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L Den Boer, Judith M Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke Katharina Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis Martin Schewe
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis. Blood 143 (26) (2024)
Judith M Boer, Uri Ilan, Aurélie Boeree, Karin P S Langenberg, Jan Koster, Marco J Koudijs, Jayne Y Hehir-Kwa, Stefan Nierkens, Corinne Rossi, Jan J Molenaar, Bianca F Goemans, Monique L den Boer, C Michel Zwaan
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience. HemaSphere 8 (7) (2024)
Inge van Outersterp, Sarah K Tasian, Caitlin Ej Reichert, Aurélie Boeree, Hester A de Groot-Kruseman, Gabriele Escherich, Judith M Boer, Monique L den Boer
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: The role of kinase type and SH3 domain. Blood (2024)
Inge van Outersterp, Sarah K Tasian, Caitlin Ej Reichert, Aurélie Boeree, Hester A de Groot-Kruseman, Gabriele Escherich, Judith M Boer, Monique L den Boer
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: The role of kinase type and SH3 domain. Blood (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat C Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L Den Boer, Judith M Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke Katharina Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis Martin Schewe
The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis. Blood 143 (26) (2024)
Inge van Outersterp, Sarah K Tasian, Caitlin E J Reichert, Aurélie Boeree, Hester A de Groot-Kruseman, Gabriele Escherich, Judith M Boer, Monique L Den Boer
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain. Blood 143 (21) (2024)
Lennart Lenk, Irène Baccelli, Anna Laqua, Julia Heymann, Claas Reimer, Anna Dietterle, Dorothee Winterberg, Caroline Mary, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Stéphanie Lara Neyton, Mylène Déramé, Sabrina Pengam, Fotini Vogiatzi, Beat Bornhauser, Jean-Pierre Bourquin, Simon Raffel, Vladyslava Dovhan, Thomas Schüler, Gabriele Escherich, Monique L den Boer, Judith M Boer, Wiebke Wessels, Matthias Peipp, Julia Alten, Željko Antić, Anke Katharina Bergmann, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis M Schewe
The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis. Blood (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Inge van Outersterp, Judith M Boer, Cesca van de Ven, Caitlin E J Reichert, Aurelie Boeree, Brian Kruisinga, Hester A de Groot-Kruseman, Gabriele Escherich, Aniko Sijs-Szabo, Anita W Rijneveld, Monique L den Boer
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations. Blood advances 8 (8) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Judith M Boer, C Michel Zwaan
When InO says no: understanding escape. Blood 144 (1) (2024)
Judith M Boer, C Michel Zwaan
When InO says no: understanding escape. Blood 144 (1) (2024)
Inge van Outersterp, Sarah K Tasian, Caitlin Ej Reichert, Aurélie Boeree, Hester A de Groot-Kruseman, Gabriele Escherich, Judith M Boer, Monique L den Boer
Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: The role of kinase type and SH3 domain. Blood (2024)
William C Earnshaw, Carmen Ortega-Sabater, Namitha Thampi, Narcís Fernandez-Fuentes, Mercedes Guerrero Murillo, Alba Martínez-Moreno, Meritxell Vinyoles, Talía Velasco-Hernandez, Clara Bueno, Juan L Trincado, Isabel Granada, Diana Campos, Carles Giménez, Judith M Boer, Monique L den Boer, Gabriel F Calvo, Mireia Camós, Jose-Luis Fuster, Pablo Velasco, Paola Ballerini, Franco Locatelli, Charles G Mullighan, Diana Carolina Johanna Spierings, Floris Foijer, Victor M Pérez-García, Pablo Menéndez
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression. EMBO molecular medicine 16 (1) (2023)
William C Earnshaw, Carmen Ortega-Sabater, Namitha Thampi, Narcís Fernandez-Fuentes, Mercedes Guerrero Murillo, Alba Martínez-Moreno, Meritxell Vinyoles, Talía Velasco-Hernandez, Clara Bueno, Juan L Trincado, Isabel Granada, Diana Campos, Carles Giménez, Judith M Boer, Monique L den Boer, Gabriel F Calvo, Mireia Camós, Jose-Luis Fuster, Pablo Velasco, Paola Ballerini, Franco Locatelli, Charles G Mullighan, Diana Carolina Johanna Spierings, Floris Foijer, Victor M Pérez-García, Pablo Menéndez
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression. EMBO molecular medicine 16 (1) (2023)
William C Earnshaw, Carmen Ortega-Sabater, Namitha Thampi, Narcís Fernandez-Fuentes, Mercedes Guerrero Murillo, Alba Martínez-Moreno, Meritxell Vinyoles, Talía Velasco-Hernandez, Clara Bueno, Juan L Trincado, Isabel Granada, Diana Campos, Carles Giménez, Judith M Boer, Monique L den Boer, Gabriel F Calvo, Mireia Camós, Jose-Luis Fuster, Pablo Velasco, Paola Ballerini, Franco Locatelli, Charles G Mullighan, Diana Carolina Johanna Spierings, Floris Foijer, Victor M Pérez-García, Pablo Menéndez
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression. EMBO molecular medicine (2023)
William C Earnshaw, Carmen Ortega-Sabater, Namitha Thampi, Narcís Fernandez-Fuentes, Mercedes Guerrero Murillo, Alba Martínez-Moreno, Meritxell Vinyoles, Talía Velasco-Hernandez, Clara Bueno, Juan L Trincado, Isabel Granada, Diana Campos, Carles Giménez, Judith M Boer, Monique L den Boer, Gabriel F Calvo, Mireia Camós, Jose-Luis Fuster, Pablo Velasco, Paola Ballerini, Franco Locatelli, Charles G Mullighan, Diana Carolina Johanna Spierings, Floris Foijer, Victor M Pérez-García, Pablo Menéndez
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression. EMBO molecular medicine 16 (1) (2023)
Femke M Hormann, Eva J Mooij, Marieke van de Mheen, H Berna Beverloo, Monique L den Boer, Judith M Boer
The impact of an additional copy of chromosome 21 in B-cell precursor acute lymphoblastic leukemia. Genes, chromosomes & cancer (2023)
Rob Pieters, Hester de Groot-Kruseman, Marta Fiocco, Femke Verwer, Merian Van Overveld, Edwin Sonneveld, Vincent H J van der Velden, H Berna Beverloo, Marc Bierings, Natasja Dors, Valerie de Haas, Peter M Hoogerbrugge, Inge M Van der Sluis, Wim Tissing, Margreet A Veening, Judith M Boer, Monique Den Boer
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
William C Earnshaw, Carmen Ortega-Sabater, Namitha Thampi, Narcís Fernandez-Fuentes, Mercedes Guerrero Murillo, Alba Martínez-Moreno, Meritxell Vinyoles, Talía Velasco-Hernandez, Clara Bueno, Juan L Trincado, Isabel Granada, Diana Campos, Carles Giménez, Judith M Boer, Monique L den Boer, Gabriel F Calvo, Mireia Camós, Jose-Luis Fuster, Pablo Velasco, Paola Ballerini, Franco Locatelli, Charles G Mullighan, Diana Carolina Johanna Spierings, Floris Foijer, Victor M Pérez-García, Pablo Menéndez
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression. EMBO molecular medicine 16 (1) (2023)
William C Earnshaw, Carmen Ortega-Sabater, Namitha Thampi, Narcís Fernandez-Fuentes, Mercedes Guerrero Murillo, Alba Martínez-Moreno, Meritxell Vinyoles, Talía Velasco-Hernandez, Clara Bueno, Juan L Trincado, Isabel Granada, Diana Campos, Carles Giménez, Judith M Boer, Monique L den Boer, Gabriel F Calvo, Mireia Camós, Jose-Luis Fuster, Pablo Velasco, Paola Ballerini, Franco Locatelli, Charles G Mullighan, Diana Carolina Johanna Spierings, Floris Foijer, Victor M Pérez-García, Pablo Menéndez
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression. EMBO molecular medicine (2023)
Kentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, Shinsuke Hirabayashi, Anke K Bergmann, Anja Möricke, Judith M Boer, Hélène Cave, Giovanni Cazzaniga, Allen Eng Juh Yeoh, Masashi Sanada, Toshihiko Imamura, Hiroto Inaba, Charles G Mullighan, Mignon L Loh, Ulrika Norén-Nyström, Lee-Yung Shih, Marketa Zaliova, Ching-Hong Pui, Oskar A Haas, Christine J Harrison, Anthony V Moorman, Atsushi Manabe
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. Leukemia (2022)
Edoardo Pennesi, Naomi Michels, Erica Brivio, Vincent H J van der Velden, Yilin Jiang, Adriana Thano, Anneke J C Ammerlaan, Judith M Boer, H Berna Beverloo, Barbara Sleight, Ying Chen, Britta Vormoor-Bürger, Susana Rives, Bella Bielorai, Claudia Rössig, Arnaud Petit, Carmelo Rizzari, Gernot Engstler, Jan Starý, Francisco J Bautista Sirvent, Christiane Chen-Santel, Benedicte Bruno, Yves Bertrand, Fanny Rialland, Geneviève Plat, Dirk Reinhardt, Luciana Vinti, Arend Von Stackelberg, Franco Locatelli, Christian Michel Zwaan
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial. Leukemia 36 (6) (2022)
Emma Kroeze, Laura Arias Padilla, Max Bakker, Judith M Boer, Melanie M Hagleitner, Birgit Burkhardt, Takeshi Mori, Andishe Attarbaschi, Jaime Verdú-Amorós, Marta Pillon, Liliya Anderzhanova, Edita Kabíčková, Alan Kwok Shing Chiang, Rejin Kebudi, Karin Mellgren, Jelena Lazic, Janez Jazbec, Jules P P Meijerink, Auke Beishuizen, Jan L C Loeffen, null null
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement. Cancers 14 (16) (2022)
Judith M Boer, Maria Grazia Valsecchi, Femke M Hormann, Željko Antić, Marketa Zaliova, Claire Schwab, Giovanni Cazzaniga, Chloé Arfeuille, Hélène Cave, Andishe Attarbaschi, Sabine Strehl, Gabriele Escherich, Toshihiko Imamura, Kentaro Ohki, Tanja A Grüber, Rosemary Sutton, Agata Pastorczak, Tim Lammens, Frédéric Lambert, Chi-Kong Li, Enrique Carrillo de Santa Pau, Steve Hoffmann, Anja Möricke, Christine J Harrison, Monique L Den Boer, Paola De Lorenzo, Ronald W Stam, Anke K Bergmann, Rob Pieters
Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study. Leukemia 35 (10) (2021)